Chromocure Stock Current Valuation
Valuation analysis of ChromoCure helps investors to measure ChromoCure's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that ChromoCure's price fluctuation is out of control at this time. Calculation of the real value of ChromoCure is based on 3 months time horizon. Increasing ChromoCure's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ChromoCure stock is determined by what a typical buyer is willing to pay for full or partial control of ChromoCure. Since ChromoCure is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ChromoCure Stock. However, ChromoCure's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 | Naive 2.9E-5 |
The intrinsic value of ChromoCure's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ChromoCure's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ChromoCure helps investors to forecast how ChromoCure stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ChromoCure more accurately as focusing exclusively on ChromoCure's fundamentals will not take into account other important factors: ChromoCure Company Current Valuation Analysis
ChromoCure's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current ChromoCure Current Valuation | 850.71 K |
Most of ChromoCure's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ChromoCure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, ChromoCure has a Current Valuation of 850.71 K. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all United States stocks is notably lower than that of the firm.
ChromoCure Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ChromoCure's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ChromoCure could also be used in its relative valuation, which is a method of valuing ChromoCure by comparing valuation metrics of similar companies.ChromoCure is currently under evaluation in current valuation category among its peers.
ChromoCure Fundamentals
| Return On Asset | -0.0806 | |||
| Current Valuation | 850.71 K | |||
| Shares Outstanding | 8.2 B | |||
| EBITDA | (121.72 K) | |||
| Net Income | (147.24 K) | |||
| Cash And Equivalents | 19.98 K | |||
| Total Debt | 800 K | |||
| Cash Flow From Operations | 173.66 K | |||
| Beta | 23.33 | |||
| Market Capitalization | 8.2 K |
About ChromoCure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ChromoCure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ChromoCure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ChromoCure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with ChromoCure
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ChromoCure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChromoCure will appreciate offsetting losses from the drop in the long position's value.Moving against ChromoCure Stock
| 0.46 | TCHH | Trustcash Holdings | PairCorr |
| 0.4 | META | Meta Platforms Aggressive Push | PairCorr |
| 0.33 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.31 | AAPL | Apple Inc | PairCorr |
The ability to find closely correlated positions to ChromoCure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ChromoCure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ChromoCure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ChromoCure to buy it.
The correlation of ChromoCure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ChromoCure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ChromoCure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ChromoCure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in ChromoCure Stock
If you are still planning to invest in ChromoCure check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ChromoCure's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |